Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS
September 28, 2023
Kusatsu/Shiga, Japan - Takara Bio Inc. announces that it has entered into a License Agreement with non-profit/charity organization, Fondazione Telethon ETS (“Telethon”) (https://www.telethon.it/en), Italy, under which Takara Bio grants Telethon a commercial license to use RetroNectin®. Under this agreement, Takara Bio provides Telethon with reliable supplies of RetroNectin®.The technologies licensed to Telethon are based on [...]
LGC Group appoints David King as Non-Executive Director and Chairman
September 28, 2023
Today, LGC announced the appointment of David P. King as Non-Executive Chairman of its Board of Directors. Euan O’Sullivan, President & Chief Executive Officer (CEO) of LGC said: "We are delighted to welcome David to LGC’s Board of Directors, given his extensive healthcare experience within the diagnostics, pharmaceutical and biotech sectors, key customer focus areas [...]
September 28, 2023
AI-driven literature extraction for thousands of rare disease genes fortifies and extends QIAGEN’s proprietary, human-certified content, providing complete bibliographic coverage of the clinical exome Enhanced AI-trained phenotype driven ranking of pathogenic variants improves accuracy and efficiency of prioritizing candidate variants New features reduce time needed for prioritization, assessment and interpretation of clinically relevant variants and [...]
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
September 28, 2023
New Kit expands suite of NGS Library Prep solutions on the BioXp® System Enabling Speed and Efficiency for Whole genome sequencing (WGS) applications with the Automated Molecular Biology Workstation SAN DIEGO -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp® NGS [...]
DNAnexus-enabled UK Biobank Research Analysis Platform Surpasses 5,000 Users in Two Years
September 28, 2023
World’s largest biomedical research resource now features more than 28 PB of data to help accelerate scientific discovery and improve human health MOUNTAIN VIEW, Calif.--DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced that the DNAnexus-enabled UK Biobank Research Analysis Platform (UKB-RAP) community has grown to more than [...]
September 28, 2023
Investments set foundation for global platform of laboratory-automation technologies serving environmental, agricultural and food-and-beverage applications BOSTON--Battery Ventures, a global, technology-focused investment firm, today announced the creation of a new laboratory-automation platform following recent acquisitions of three complementary companies: Skalar Analytical, PromoChrom Technologies and LCTech. Skalar Analytical, based in Breda, the Netherlands, manufactures a range of [...]
BioFlyte Successfully Validates Aerosolized Fentanyl Detection Capabilities
September 28, 2023
Following in-house and third-party validation testing, BioFlyte adds aerosolized fentanyl to its classification library and becomes only market solution proven to simultaneously sample for both chemical and biological threat agents ALBUQUERQUE, N.M. — BioFlyte, a bioaerosol surveillance firm with a disruptive new class of fieldable biological threat collection, detection, and identification solutions, today announced that it [...]
Sartorius forms partnership with SPARTA Biodiscovery on novel nanoparticle analysis platform
September 28, 2023
SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs Sartorius enters into minority shareholding GÖTTINGEN, Germany -- The life science group Sartorius and UK-based startup SPARTA Biodiscovery have agreed to partner on SPARTA’s analysis platform, which helps speed up the development, manufacture, and quality control of nanoparticles for [...]
Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers
September 28, 2023
Superior thermal performance and enhanced usability for PCR applications, such as sequencing, cloning, and genotyping. HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR [...]
September 27, 2023
Empowering Researchers with Advanced End-to-End Analysis Tools for Single-Cell and Genetic Variation Studies. We’re thrilled to announce the much-anticipated arrival of OmicsBox 3.1, a release that brings significant improvements to single-cell data analysis with UMI-based technology support and introduces a functional enrichment tool for genetic variation analysis. It also enhances OmicsBox’s long-read transcriptome analysis options, [...]

